We are live on ! Find out more
DXR icon

Daxor
DXR

5 hedge funds and large institutions have $893K invested in Daxor in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 55 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.07% less ownership

Funds ownership: 1.74%1.67% (-0.07%)

4% less capital invested

Capital invested by funds: $926K → $893K (-$33K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
5
Holders Change
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$29.6K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$627K
Renaissance Technologies
2
Renaissance Technologies
New York
$224K -$56.1K -4,200 -20%
TRCT
3
Tower Research Capital (TRC)
New York
$29K +$29.6K +2,214 New
UBS Group
4
UBS Group
Switzerland
$11K -$1.39K -104 -11%
Morgan Stanley
5
Morgan Stanley
New York
$2K
Wells Fargo
6
Wells Fargo
California
-$8K -600 Closed

DXR Hedge Fund Activity: Q3 2022 in Review

5 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q3 2022, worth a combined $893K — down 3.6% from $926K a quarter earlier.

Fund positioning in DXR was balanced in Q3 2022: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.

The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $29.6K. The largest seller was Renaissance Technologies, cutting an estimated $56.1K.

  • 5 institutional investors held Daxor (DXR) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $893K of Daxor stock for Q3 2022, down 3.6% quarter-over-quarter.
  • 1 fund opened new Daxor positions in Q3 2022 and 1 closed out, a net change of 0 holders.
  • The largest Daxor buyer in Q3 2022 was Tower Research Capital (TRC), an estimated $29.6K added.
  • The largest Daxor seller in Q3 2022 was Renaissance Technologies, an estimated $56.1K sold.

Based on aggregated 13F filings for Q3 2022.